Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: J Sex Res. 2022 Apr 18;60(9):1283–1296. doi: 10.1080/00224499.2022.2059649

Table 5.

Hormonal Contraceptive Use Vs. Non-Use Predicting Sexual Intercourse, by Method Type: Results from 3-Level Generalized Multilevel Models (5 Separate Models for the 5 Method Types)

B SE p AOR AOR 95% C.I.

Woman level (Level 3)
Proportion of weeks used
 Pill 0.25 0.09 0.006 1.28 (1.071,1.526)
 Patch 0.44 0.77 0.573 1.55 (0.339,7.052)
 Ring 0.38 0.26 0.136 1.47 (0.886,2.436)
 Injectable 0.34 0.19 0.083 1.40 (0.956,2.054)
 IUD/Implant −0.23 0.37 0.535 0.80 (0.389,1.633)
Relationship Level (Level 2)
Proportion of weeks used
 Pill −0.01 0.15 0.974 0.99 (0.735,1.347)
 Patch −1.35 0.86 0.118 0.26 (0.048,1.410)
 Ring 0.67 0.55 0.226 1.95 (0.661,5.773)
 Injectable −0.08 0.48 0.868 0.92 (0.361,2.362)
 IUD/Implant −0.81 0.55 0.142 0.44 (0.151,1.314)
Week level (Level 1)
Used that week (yes/no)
Pill 1.04 0.06 <0.001 2.83 (2.513,3.180)
 Patch 0.50 0.27 0.067 1.65 (0.965,2.821)
Ring 0.74 0.19 <0.001 2.10 (1.445,3.065)
Injectable 0.57 0.12 <0.001 1.77 (1.404,2.221)
IUD/Implant 1.56 0.21 <0.001 4.76 (3.128,7.250)

Note. B = Unstandardized coefficients. SE = Standard error. AOR = Adjusted odds ratio. Five separate models were run, one each for the five different method types, with the upper-level variables corresponding to that method type. Bold font indicates significant level-1 associations. Full results available in supplemental materials.